Vermox (Mebendazole) - Indications and Dosage

INDICATIONS AND USAGE

VERMOX® (mebendazole) is indicated for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.

Efficacy varies as a function of such factors as pre-existing diarrhea and gastrointestinal transit time, degree of infection, and helminth strains. Efficacy rates derived from various studies are shown in the table below:

DOSAGE AND ADMINISTRATION

The same dosage schedule applies to children and adults. The tablet may be chewed, swallowed, or crushed and mixed with food.

If the patient is not cured three weeks after treatment, a second course of treatment is advised. No special procedures, such as fasting or purging, are required.

HOW SUPPLIED

VERMOX® (mebendazole) is available as chewable tablets, each containing 100 mg of mebendazole, and is supplied in boxes of twelve tablets and boxes of sixty tablets.

Store at controlled room temperature 59°-77°F (15°-25°C).

McNeil Consumer & Specialty Pharmaceuticals

Fort Washington, PA 19034

Rev. October 1999

NDC 50580-070-12 (blister package of 12)

NDC 50580-070-60 (blister package of 60)

Distributed by:

McNeil Consumer Healthcare

DIVISION OF McNEIL-PPC, INC.

FORT WASHINGTON, PA 19034 USA

©MCN-PPC, INC. '99

Revised October 1999

U.S. Patent 3,657,267